Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Published Online: 2014-05-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Andrea Marshall•Ashita M Waterston•Charles G Kelly•Ernest Marshall•Gemma Young•Janet A Dunn•Jenny P Nobes•Maria Marples•Mark Harries•Mark R Middleton•Martin Gore•Neville Davidson•Paul D Nathan•Paul Lorigan•Pippa G Corrie•Ruth E Board•Sarah J Danson•Satish Kumar•Stephen J Houston•Steve Nicholson
